Fwd: Science X Newsletter Sunday, Dec 14

---------- Forwarded message ----------
From: Newsletter Phys.org <not-for-reply@physorg.com>
Date: Mon, Dec 15, 2014 at 2:20 AM
Subject: Science X Newsletter Sunday, Dec 14
To: Pascal Alter <pascal.alter@gmail.com>

Dear Pascal Alter,

Here is your customized Phys.org Newsletter for December 14, 2014:

Spotlight Stories Headlines

- Cancer patients testing drugs on mouse 'avatars'
- Facebook doesn't love the idea of a 'dislike' button
- Oculus boosts virtual reality development with acquisitions
- Fun cryptography app pleases students and teachers
- Low-fat diet may help some women beat breast cancer, study suggests
- Is an understanding of dark matter around the corner? Experimentalists unsure
- Enviro-tracker is wearable for citizen monitoring
- New Bond script stolen in Sony hack

Astronomy & Space news

Defense satellite launches from California coast A U.S. defense satellite launched from California's central coast after weather delays caused by a major storm that drenched the state.

Medicine & Health news

	Cancer patients testing drugs on mouse 'avatars' Scientists often test drugs in mice. Now some cancer patients are doing the same—with the hope of curing their own disease.
	Low-fat diet may help some women beat breast cancer, study suggests Almost anyone would benefit by reducing the amount of fat in their diet. But the upside could be especially big for women with breast cancer.
	Fat cells reprogrammed to increase fat burning White adipose tissue stores excess calories as fat that can be released for use in other organs during fasting. Mammals also have small amounts of brown adipose tissue, which primarily acts as an effective fat burner for the production of heat. Now researchers from the University of Southern Denmark have uncovered the mechanism by which white fat cells from humans gets reprogrammed to become browner.
India court blocks Bayer generic drug appeal An Indian court has rejected German drug giant Bayer's bid to block a generic version of its blockbuster cancer treatment Nexavar by a local drugmaker, a move hailed by activists on Saturday.
EU food labels to help allergy sufferers New EU labelling rules taking effect Saturday require restaurants and other businesses to tell customers if their food could trigger allergies or raise other health concerns.
	Ebola in 2015 - end of the line for a killer? After decades making brief, murderous forays from central Africa's forests, Ebola erupted into a global emergency in 2014, yet its success could spell its downfall as scientists scramble to relegate it to a footnote of medical history.
	After infant dies, health officials urge caution in children's use of probiotic supplement Federal health officials are cautioning consumers about a probiotic dietary supplement for children that has caused the death of a premature Connecticut baby and may be dangerous to others.
	Mortality not up with pregnancy-associated malignant melanoma (HealthDay)—Cause-specific mortality does not differ significantly for women and girls with malignant melanoma (MM) diagnosed during pregnancy and up to two years postpartum (pregnancy-associated MM [PAMM]) and with non-PAMM, according to a study published in the December issue of the Journal of the American Academy of Dermatology.
	Multidose eye drop approach approved by joint commission (HealthDay)—A policy and procedural approach to the use of multidose eye drops has been approved by The Joint Commission and can reduce costs for patients and facilities, according to an article published in the December issue of JAMA Ophthalmology.
	Thyroidectomy, statins may cut risk of graves ophthalmopathy (HealthDay)—Both thyroidectomy and statin use are associated with lower risk of developing thyroid-associated ophthalmopathy (TAO) in individuals with Graves disease (GD), according to research published online Dec. 11 in JAMA Ophthalmology.
	CDC: PCPs to inform families of sickle cell trait in newborns (HealthDay)—Primary care providers should offer educational materials and provide genetic counseling to families when they receive positive results for sickle cell trait (SCT) at the time of newborn screening, according to a report published in the Dec. 12 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
	SABCS: Genetic test may help predict DCIS recurrence (HealthDay)—For women who have ductal carcinoma in situ surgically removed, a genetic test may help predict the odds of a recurrence, according to research presented at the annual San Antonio Breast Cancer Symposium, held from Dec. 9 to 13 in San Antonio.
	Tips offered for docs to manage their online reputation (HealthDay)—Physicians can manage their online reputation, according to a report from the American Medical Association (AMA).
	FDA: Cyramza approval now includes non-small-cell lung CA (HealthDay)—U.S. Food and Drug Administration approval of the anti-cancer drug Cyramza (ramucirumab) has been expanded to include aggressive non-small-cell lung cancer (NSCLC), the agency said Friday.
	FDA: Ziprasidone can cause rare, serious adverse drug reaction (HealthDay)—The antipsychotic medicine ziprasidone (Geodon) and generic versions of the drug can cause a rare, serious skin reaction that can progress to affect other parts of the body, the U.S. Food and Drug Administration says.
	Microbial flora ID'd in patients undergoing rhinoplasty (HealthDay)—For patients undergoing rhinoplasty, preoperative nasal culture can identify microbial flora that indicate risk of postoperative infection, according to research published online Dec. 11 in JAMA Facial Plastic Surgery.
	Post-bariatric surgery weight loss may ease knee pain (HealthDay)—Current evidence, though limited, suggests that bariatric surgery with subsequent marked weight loss may reduce knee complaints in morbidly obese adults, according to research published online Dec. 8 in Obesity Reviews.
	Cervical discectomy without fusion cost-effective strategy (HealthDay)—Anterior cervical discectomy without fusion (ACD) may be the most effective and cost-effective alternative for the treatment of one-level cervical disc disease, according to research published in the Dec. 1 issue of Spine.
Deplaning in Va. delayed while Ebola scare checked Passengers disembarking from a commercial flight in Richmond, Virginia, on Friday were delayed by about an hour while authorities ruled out Ebola as a cause of a fellow passenger's symptoms.

---

This email is a free service of Phys.org
You received this email because you subscribed to our list.
(...)
You are subscribed as pascal.alter@gmail.com